| Literature DB >> 6624797 |
J D Martin, R Hähnel, A J McCartney, T L Woodings.
Abstract
This study demonstrates a significantly increased survival time for women with estrogen receptor-positive adenocarcinoma of the endometrium when compared with that of those with estrogen receptor-negative tumors (p less than 0.05). This prognostic factor provides information which is additional to, and independent of, that provided by the histologic grade and myometrial penetration of the tumor.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6624797 DOI: 10.1016/0002-9378(83)91119-5
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN: 0002-9378 Impact factor: 8.661